Symptomatic Treatment of MS - European Multiple Sclerosis Platform

203. Prosiegel M, Heintze M, Wagner-Sonntag E, Hannig C, Wuttge-Hannig A, Yassouridis A (2002)
Deglutition disorders in neurological patients. A prospective study of diagnosis, pattern of
impairment, therapy and outcome. Nervenarzt 73:364-370
204. Prosiegel M, Schelling A, Wagner-Sonntag E (2004) Dysphagia and multiple sclerosis. Int MS J
11:22-31
205. Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN (2002) Efficacy
and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre
phase 2 study. J Neurol Neurosurg Psychiatry 72:179-183
206. Rammohan KW, Lynn DJ (2005) Modafinil for fatigue in MS: a randomized placebo-controlled
double-blind study. Neurology 65: 1995-1997
207. Ramsaransing G, Zwanikken C, De Keyser J (2000) Worsening of symptoms of multiple sclerosis
associated with carbamazepine. BMJ 320:1113
208. Reess J, Haas J, Gabriel K, Fuhlrott A, Fiola M (2002) Both paracetamol and ibuprofen are equally
effective in managing flu-like symptoms in relapsing-remitting multiple sclerosis patients during
interferon beta-1a (AVONEX) therapy. Mult Scler 8:15-18
209. Reitz A, Stöhrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J, Burgdorfer H, Gocking K, Madersbacher
H, Schumacher S, Richter R, von Tobel J, Schurch B (2004) European experience of 200 cases
treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due
to neurogenic detrusor overactivity. Eur Urol 45:510-515
210. Rice GP, Lesaux J, Vandervoort P, Macewan L, Ebers GC (1997) Ondansetron, a 5-HT3 antagonist,
improves cerebellar tremor. J Neurol Neurosurg Psychiatry 62:282-284
211. Rio J, Nos C, Bonaventura I, Arroyo R, Genis D, Sureda B, Ara JR, Brieva L, Martin J, Saiz A, Sanchez Lopez
F, Prieto JM, Roquer J, Dorado JF, Montalban X (2004) Corticosteroids, ibuprofen, and acetaminophen
for IFNβ-1a flu symptoms in MS. A randomized trial. Neurology 63:525-528
212. Roe B, Williams K, Palmer M (2000) Bladder training for urinary incontinence in adults. Cochrane
Database Syst Rev CD001308
213. Rog DJ, Nurmikko TJ, Friede T, Young CA (2005). Randomized, controlled trial of cannabis-based
medicine in central pain in multiple sclerosis. Neurology 65: 812–819.
214. Rontal E, Rontal M, Wald J, Rontal D (1999) Botulinum toxin injection in the treatment of vocal
fold paralysis associated with multiple sclerosis. A case report. J Voice 13:274-279
215. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U (2004) Pregabalin for the treatment of painful
diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110:628-638
216. Rossini PM, Pasqualetti P, Pozzilli C, Grasso MG, Millefiorini E, Graceffa A, Carlesimo GA, Zibellini G,
Caltagirone C (2001) Fatigue in progressive multiple sclerosis: results of a randomized, doubleblind,
placebo-controlled, crossover trial of oral 4-aminopyridine. Mult Scler 7:354-358
217. Ruffion A, Capelle O, Paparel P, Leriche B, Leriche A, Grise P (2006) What is the optimum dose of
55 EMSP, Symptomatic Treatment of Multiple Sclerosis, December 2006 - revised in April 2008